TELA Bio (TELA) Income from Continuing Operations (2018 - 2026)
TELA Bio's (TELA) quarterly Income from Continuing Operations came in at 12273000.0 in Q1 2026, down 8.96% year-on-year from 13480553.1 in Q1 2025, and down 37.95% quarter-over-quarter from 8897000.0 in Q4 2025.
TELA Bio (TELA) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TELA Bio's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 12273000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 8.96% year-over-year to 12273000.0 in Q1 2026; TTM through Mar 2026 was 39696000.0, a 695.83% decrease from a year earlier, with the FY2025 full-year figure at 38687000.0, down 550.27% from the prior year.
- Income from Continuing Operations slipped to 12273000.0 in Q1 2026 per TELA's latest filing, from 8897000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 29248000.0 in Q4 2024 and bottomed at 13002000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 11171000.0 (2022), against an average of 8378000.0.
- Across the five-year window, Income from Continuing Operations soared 324.95% in 2024 and sank 130.42% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 9669000.0 in 2022, then tumbled by 34.47% to 13002000.0 in 2023, then soared by 324.95% to 29248000.0 in 2024, then sank by 130.42% to 8897000.0 in 2025, then slumped by 37.95% to 12273000.0 in 2026.
- Per Business Quant, the three latest TELA Income from Continuing Operations figures stand at 12273000.0 (Q1 2026), 8897000.0 (Q4 2025), and 8603000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -12.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -13.00 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -12.36 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -9.67 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -11.18 Mn |
| Dec 31, 2021 | -8.55 Mn |
| Sep 30, 2021 | -11.32 Mn |
| Jun 30, 2021 | -14.71 Mn |